API Market: 5-Year Trends in USDMF and CEP Approvals
The API market is evolving rapidly, with regulatory approvals on the rise and manufacturing shifting towards Asia. Over the past five years, USDMF and CEP approvals have grown significantly, reflecting increasing demand for APIs in key therapeutic areas. India and China have emerged as dominant players, reshaping the industry landscape. What do these trends mean for the future of pharmaceutical manufacturing? Explore our latest insights.
Download Whitepaper for free
- Rapid growth in USDMF and CEP approvals, driven by rising API demand
- India and China lead API production
- Patent-protected APIs drive growth
free download
API Market trends with growth, leaders and innovation
Drop your email, and our QYOBO team will reach out to you shortly!
free download
5-Year Trends in USDMF and CEP Approvals
Drop your email, and our QYOBO team will reach out to you shortly!
By submitting this form, I declare that I have read and understood QYOBO’s privacy policy and give my explicit consent to the processing of my personal data for the stated purposes. I am aware that I can revoke my consent at any time.
